Melatonin Vitabalans

Melatonin, the active ingredient in Melatonin Vitabalans, is a melatonin receptor agonist presented as an oral formulation for oral use. It is used to help regulate sleep‑wake cycles and is indicated for insomnia, jet lag and other circadian rhythm sleep disorders in adults. GNH USA supplies Melatonin Vitabalans as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Melatonin acts on the melatonin receptor pathway to support normal sleep regulation. - Insomnia: helps reduce sleep onset latency and improve sleep quality. - Jet lag: assists in adjusting the internal clock after rapid east‑west travel. - Circadian rhythm sleep disorders: supports synchronization of disrupted sleep‑wake cycles.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate discomfort. - Dizziness: transient sense of light‑headedness. - Daytime sleepiness: residual drowsiness after dosing. - Nausea: occasional gastrointestinal upset. - Vivid dreams: unusual or intense dreaming. - Mild abdominal discomfort: occasional stomach upset.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, swelling, or difficulty breathing. - Severe depression or mood changes: rare exacerbation of depressive symptoms. - Hallucinations or psychotic symptoms: very uncommon but reported. - Significant hypotension: marked drop in blood pressure leading to faintness.

When considering melatonin therapy, certain safety measures are recommended. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a physician. - Elderly patients: start with the lowest effective dose and monitor response. - Concomitant CNS depressants: observe for additive sedation. - Driving or operating machinery: exercise caution due to possible drowsiness. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Melatonin may interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): may increase bleeding tendency. - Immunosuppressants (e.g., cyclosporine): potential reduction in immunosuppressive effect. - Oral contraceptives: possible alteration of hormone levels.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines): additive sedative effect. - Caffeine-containing products: may diminish melatonin’s sleep‑promoting action. - Alcohol: can enhance drowsiness and impair coordination.